MARSHALL WACE, LLP - UROVANT SCIENCES LTD ownership

UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 20 filers reported holding UROVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of UROVANT SCIENCES LTD
ValueSharesWeighting
Q4 2020$556,000
+569.9%
34,494
+547.9%
0.00%
+200.0%
Q4 2019$83,000
-87.2%
5,324
-91.8%
0.00%
-66.7%
Q1 2019$650,00064,6580.00%
Other shareholders
UROVANT SCIENCES LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Pekin Hardy Strauss, Inc. 424,127$3,961,0000.81%
Samsara BioCapital, LLC 157,480$1,471,0000.41%
Perceptive Advisors 2,366,831$22,106,0000.32%
Wildcat Capital Management, LLC 94,687$884,0000.28%
Vigilare Wealth Management 13,000$121,0000.13%
Alyeska Investment Group, L.P. 620,889$5,799,0000.09%
LVW Advisors, LLC 38,812$363,0000.08%
Baker Brothers Advisors 978,505$9,139,0000.04%
KORNITZER CAPITAL MANAGEMENT INC /KS 51,100$477,0000.01%
Marshall Wace North America L.P. 42,546$397,0000.00%
View complete list of UROVANT SCIENCES LTD shareholders